Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
ritonavir thyroidhormones

decreases concentration

Unknown Anecdotal
ritonavir tizanidine

decreases exposure

Unknown Study
ritonavir ulipristal

decreases efficacy

Unknown Anecdotal
ritonavir valproate

decreases concentration

Unknown Anecdotal
rizatriptan ergotamine

increases risk of vasoconstriction

Unknown
ropeginterferonalfa antipsychotics,secondgeneration

increases exposure

Unknown Theoretical
ropeginterferonalfa atomoxetine

increases exposure

Unknown Theoretical
ropeginterferonalfa betablockers,selective

increases exposure

Unknown Theoretical
ropeginterferonalfa eliglustat

increases exposure

Unknown Theoretical
ropeginterferonalfa methadone

increases exposure

Unknown Theoretical
ropeginterferonalfa nebivolol

increases exposure

Unknown Theoretical
ropeginterferonalfa opioids

increases exposure

Unknown Theoretical
ropeginterferonalfa risperidone

increases exposure

Unknown Theoretical
ropeginterferonalfa vortioxetine

increases exposure

Unknown Theoretical
rucaparib afatinib

increases exposure

Unknown Study
rucaparib agomelatine

increases exposure

Unknown Study
rucaparib anaesthetics,local

increases exposure

Unknown Theoretical
rucaparib anagrelide

increases exposure

Unknown Theoretical
rucaparib berotralstat

increases exposure

Unknown Study
rucaparib chlorpromazine

increases exposure

Unknown Theoretical
rucaparib docetaxel

increases exposure

Unknown Theoretical
rucaparib fidaxomicin

increases exposure

Unknown Study
rucaparib loxapine

increases exposure

Unknown Theoretical
rucaparib melatonin

increases exposure

Unknown Theoretical
rucaparib nintedanib

increases exposure

Unknown Study
rucaparib paclitaxel

increases exposure

Unknown Theoretical
rucaparib phenothiazines

increases exposure

Unknown Theoretical
rucaparib phosphodiesterasetype-

increases exposure

Unknown Theoretical
rucaparib rasagiline

increases exposure

Unknown Study
rucaparib relugolix

increases exposure

Unknown Study
rucaparib riluzole

increases exposure

Unknown Theoretical
rucaparib rimegepant

increases exposure

Unknown Theoretical
rucaparib roflumilast

increases exposure

Unknown Theoretical
rucaparib ropivacaine

increases exposure

Unknown Theoretical
rucaparib talazoparib

increases exposure

Unknown Study
rucaparib taxanes

increases exposure

Unknown Theoretical
rucaparib topotecan

increases exposure

Unknown Study
rucaparib trametinib

increases concentration

Unknown Theoretical
rucaparib triptans

increases exposure

Unknown Theoretical
rucaparib vincaalkaloids

increases exposure

Unknown Theoretical
rucaparib zolmitriptan

increases exposure

Unknown Theoretical
safinamide amfetamines

increases risk of severehypertension

Unknown Theoretical
safinamide beta

increases risk of severehypertension

Unknown Theoretical
safinamide linezolid

increases risk of adverseeffects

Unknown Theoretical
safinamide opioids

increases risk of adverseeffects

Unknown Theoretical
safinamide pethidine

increases risk of adverseeffects

Unknown Theoretical
sarilumab atorvastatin

decreases exposure

Unknown Study
sarilumab combinedhormonalcontraceptives

decreases exposure

Unknown Theoretical
sarilumab simvastatin

decreases exposure

Unknown Study
sarilumab statins

decreases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.